(Q79281122)

English

Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial

scientific article published on 01 December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

inflammatory breast cancer

1 reference

based on heuristic

inferred from title

author name string

Corinne Veyret

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Christelle Levy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Philippe Chollet

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Yacine Merrouche

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Henri Roche

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Pierre Kerbrat

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Pierre Fumoleau

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Pierre Fargeot

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Pierre Clavere

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Bernard Chevallier

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

107

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

2535-2544

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Inflammatory breast cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous 5-fluorouracil infusion in refractory carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year outcome after combined modality therapy for inflammatory breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy for inflammatory breast cancer: impact of doxorubicin-based therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in inflammatory breast cancer and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction Chemotherapy with Cisplatin, Doxorubicin, and Cyclophosphamide (CAP) in a Combined Modality Approach for Locally Advanced and Inflammatory Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Multimodality therapy in inflammatory breast cancer: is there a place for surgery?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of surgery in the treatment of inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Multimodal treatment for inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Two different classes of therapy-related and de-novo acute myeloid leukemia?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Case control study of prognostic markers and disease outcome in inflammatory carcinoma breast: a unique clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22227

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22227

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054108%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79281122&oldid=1587670191"